Suchergebnisse - "Eriksson, B I"

PubPharm (5)

1

Oral dabigatran versus enoxaparin for thromboprophylaxis after primary total hip arthroplasty (RE-NOVATE II*). A randomised, double-blind, non-inferiority trial

enthalten in: Thrombosis and haemostasis | 2011

von Eriksson, B. | Dahl, O. | Huo, M. | +106

CommentIn: Thromb Haemost. 2011 Apr;105(4):571-3. - PMID 21359412

2

Dabigatran versus enoxaparin for prevention of venous thromboembolism after hip or knee arthroplasty : a pooled analysis of three trials

enthalten in: Thrombosis research | 2010

von Friedman, R. | Dahl, O. | Rosencher, N. | +8

CommentIn: Thromb Res. 2010 Sep;126(3):164-5. - PMID 20542545

3

Oral dabigatran etexilate vs. subcutaneous enoxaparin for the prevention of venous thromboembolism after total knee replacement : the RE-MODEL randomized trial

enthalten in: Journal of thrombosis and haemostasis : JTH | 2007

von Eriksson, B. | Dahl, O. | Rosencher, N. | +10

CommentIn: J Thromb Haemost. 2007 Nov;5(11):2175-7. - PMID 17764539

4

A new oral direct thrombin inhibitor, dabigatran etexilate, compared with enoxaparin for prevention of thromboembolic events following total hip or knee replacement : the BISTRO II randomized trial

enthalten in: Journal of thrombosis and haemostasis : JTH | 2005

von Eriksson, B. | Dahl, O. | Büller, H. | +9

5

Dose escalating safety study of a new oral direct thrombin inhibitor, dabigatran etexilate, in patients undergoing total hip replacement : BISTRO I

enthalten in: Journal of thrombosis and haemostasis : JTH | 2004

von Eriksson, B. | Dahl, O. | Ahnfelt, L. | +5

1
[1]